Quantcast

Latest Atypical teratoid rhabdoid tumor Stories

2013-12-10 10:35:18

Washington University Pediatric Cancer Genome Project study identifies drugs that enhance oxidative stress as possible weapon against most common pediatric soft tissue tumor Drugs that enhance a process called oxidative stress were found to kill rhabdomyosarcoma tumor cells growing in the laboratory and possibly bolstered the effectiveness of chemotherapy against this aggressive tumor of muscle and other soft tissue. The findings are the latest from the St. Jude Children’s Research...

2013-09-23 12:40:17

When used to treat pediatric patients with intracranial malignant tumors, proton therapy may limit the toxicity of radiation therapy while preserving tumor control, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. Typically, central nervous system malignancies are treated with surgical resection and post-operative radiation therapy. Proton therapy, an external beam radiation therapy in which protons deliver precise...

2013-09-13 08:14:51

Results to be presented at ECC2013 will pave the way for personalized treatment A further step along the road to the personalization of cancer medicine, where treatment is based on the individual molecular characteristics of tumors rather than their primary site, will be presented at the 2013 European Cancer Congress (ECC2013), which starts on Friday 27 September in Amsterdam, The Netherlands. Dr Christophe Le Tourneau, Head of the Phase I Programme at the Institut Curie, Paris, France,...

2013-07-24 10:14:56

Noninvasive molecular diagnosis could guide, improve treatment choice Massachusetts General Hospital (MGH) researchers and their colleagues have used digital versions of a standard molecular biology tool to detect a common tumor-associated mutation in the cerebrospinal fluid (CSF) of patients with brain tumors. In their report being published in the open-access journal Molecular Therapy – Nucleic Acids, the investigators describe using advanced forms of the...

2013-07-19 23:17:03

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on the discovery of a Nano drug that may aid in treatment of brain tumors. New York, NY (PRWEB) July 19, 2013 On July 19, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on the discovery of a Nano drug, SapC-DOPS, that may aid in treating brain tumors. According to a July 17, 2013 article published on MedicalXpress.com entitled...

2013-05-07 23:03:28

Advocates from across the country joined the National Brain Tumor Society in meeting with congressional leaders to discuss the importance of cancer research funding and oral chemotherapy parity. Boston, MA (PRWEB) May 07, 2013 National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, today held their annual “Head to the Hill” advocacy day in Washington, D.C. The event drew hundreds of brain tumor advocates from across the...

2013-05-06 20:49:32

Researchers at the Stanford University School of Medicine have identified a group of proteins that are mutated in about one-fifth of all human cancers. The finding suggests that the proteins, which are members of a protein complex that affects how DNA is packaged in cells, work to suppress the development of tumors in many types of tissues. The broad reach of the effect of mutations in the complex, called BAF, rivals that of another well-known tumor suppressor called p53. It also furthers...

2013-05-03 23:18:19

Voices Against Brain Cancer, an organization dedicated to brain tumor research and advocacy, comments on an article discussing a new finding that may help in diagnosing and treating certain pediatric brain tumor cases. New York, NY (PRWEB) May 03, 2013 On May 3, Voices Against Brain Cancer (VABC), an organization dedicated to brain tumor research and advocacy, comments on an article discussing a new finding that may help doctors in classifying and treating certain pediatric brain tumors....

2013-04-16 13:33:24

Researchers with the Institute of Urologic Oncology and the Department of Urology at UCLA have classified kidney cancer into several unique subtypes, a finding that will help physicians tailor treatment to individual patients and that moves cancer care one step closer to personalized medicine. The finding is the result of 10 years of UCLA researchers studying kidney cancers at the genetic and molecular levels, conducting chromosomal analyses in an effort to identify what mutations may be...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related